Foto del docente

Ilaria Re

Adjunct professor

Department of Pharmacy and Biotechnology

Publications

  • Gatto, F.; Re, I. Circular Bioeconomy Business Models to Overcome the Valley of Death. A Systematic Statistical Analysis of Studies and Projects in Emerging Bio-Based Technologies and Trends Linked to the SME Instrument Support. Sustainability 2021, 13, 1899. doi: 10.3390/su13041899
  • Daniotti, S.; Re, I. Marine Biotechnology: Challenges and Development Market Trends for the Enhancement of Biotic Resources in Industrial Pharmaceutical and Food Applications. A Statistical Analysis of Scientific Literature and Business Models. Mar. Drugs 2021, 19, 61. doi: 10.3390/md19020061
  • Environmental Guideline for Contaminated Soil Bioremediation, doi: 10.13140/RG.2.2.17611.82721
  • Henzen E., Re I., Bosco D. Soil pollution by hydrocarbons in Italy. A mapping of the state of reclamation of the Sites of National and Regional Interest, 2019
  • Balzarotti M., Re I., Bosco D. Towards a circular bioeconomy for the Lombardy Region. Industrial case studies for biopolymers production, 2019
  • D’Imporzano G., Re I., Spina F., Varese C., Puglisi E., Spini G., Gramellini C., Zaccanti G., Beltrametti F., Bava A., Adani F. Optimizing bioremediation of hydrocarbon polluted soil by Life Cycle Assessment (LCA) approach. 2018, Environmental Engineering and Management Journal
  • Horizon 2020: Focus on Industrial Biotechnology, Guide to Public Fund Raising, Annex 1 Vol. 1, 2017
  • Bioremediation, revegetation and environmental recovery in the Ex-Carbochemistry of Fidenza. Recover n. 37, XI 2016
  • Public Funds in Italy: National incentives for innovation, Guide to Public Fund Raising Vol. 2, 2014
  • Public Fund Raising: this is how it is done. Italbiotec Guides for European, national and regional incentives for research and innovation, I.Re, D.Bosco, R. Lorenzetti at AboutPharma and Medical Devices, n. 1, 2013
  • European's support: EU funds and structural funds, Guide to the Public Fund Raising Vol. I, 2013

Latest news

At the moment no news are available.